Literature DB >> 2215903

Does the washout phenomenon of Tc-99m HM-PAO correlate to the "filling-in" phenomenon of I-123 IMP with brain SPECT?

K Hayashida1, T Nishimura, S Imakita, T Uehara.   

Abstract

Using SPECT, the time course of brain uptake was compared between N-isopropyl-p-[I-123]-iodoamphetamine (I-123 IMP) and Tc-99m d,l hexamethyl-propyleneamine oxime (Tc-99m HM-PAO). Of 14 patients with cerebrovascular disease showing areas of the "filling-in phenomenon" (i.e. delayed uptake) with I-123 IMP brain SPECT, 7 exhibited persistent defects with Tc-99m HM-PAO (Group I), and 7 showed early washout after the initial uptake (Group II). The filling-in of I-123 IMP did not always correlate to the washout region of Tc-99m HM-PAO. The temporal changes were also confirmed by semiquantitative analysis. While the filling-in of I-123 IMP was affected by many factors, the washout of Tc-99m HM-PAO was attributed to significant reduction of Tc-99m HM-PAO in the plasma. Delayed imaging of the brain with Tc-99m HM-PAO using SPECT may give a more accurate estimate of regional cerebral blood flow in cerebrovascular disease, because it should be lees effected by cerebral blood volume.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2215903     DOI: 10.1007/bf00589111

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  13 in total

1.  Interpretation of 99mTc-HMPAO washout after stroke.

Authors:  F W Smith
Journal:  Lancet       Date:  1989-02-18       Impact factor: 79.321

2.  Filling out phenomenon with technetium-99m HM-PAO brain SPECT at the site of mild cerebral ischemia.

Authors:  K Hayashida; T Nishimura; S Imakita; T Uehara
Journal:  J Nucl Med       Date:  1989-05       Impact factor: 10.057

3.  Of cerebral blood flow, stroke and SPECT.

Authors:  R H Ackerman
Journal:  Stroke       Date:  1984 Jan-Feb       Impact factor: 7.914

4.  Tomographic assessment of cerebral perfusion using a single-photon emitter (krypton-81m) and a rotating gamma camera.

Authors:  F Fazio; C Fieschi; M Collice; M Nardini; F Banfi; M Possa; F Spinelli
Journal:  J Nucl Med       Date:  1980-12       Impact factor: 10.057

5.  Cerebral uptake and retention of 99Tcm-hexamethylpropyleneamine oxime (99Tcm-HM-PAO).

Authors:  R A Holmes; S B Chaplin; K G Royston; T J Hoffman; W A Volkert; D P Nowotnik; L R Canning; S A Cumming; R C Harrison; B Higley
Journal:  Nucl Med Commun       Date:  1985-08       Impact factor: 1.690

6.  Amines for brain tomoscintigraphy.

Authors:  J L Moretti; L Cinotti; P Cesaro; G Defer; Y Joulin; A Sergent; N Vigneron; J R Rapin; C Raynaud
Journal:  Nucl Med Commun       Date:  1987-07       Impact factor: 1.690

7.  Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion.

Authors:  R D Neirinckx; L R Canning; I M Piper; D P Nowotnik; R D Pickett; R A Holmes; W A Volkert; A M Forster; P S Weisner; J A Marriott
Journal:  J Nucl Med       Date:  1987-02       Impact factor: 10.057

8.  Early and delayed SPECT using N-isopropyl p-iodoamphetamine iodine 123 in cerebral ischemia. A prognostic index for clinical recovery.

Authors:  G Defer; J L Moretti; P Cesaro; A Sergent; C Raynaud; J D Degos
Journal:  Arch Neurol       Date:  1987-07

9.  Cerebral dynamics of N-isopropyl-(123I)p-iodoamphetamine.

Authors:  H Creutzig; O Schober; P Gielow; R Friedrich; H Becker; H Dietz; H Hundeshagen
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

10.  N-isopropyl-[123I] p-iodoamphetamine: single-pass brain uptake and washout; binding to brain synaptosomes; and localization in dog and monkey brain.

Authors:  H S Winchell; W D Horst; L Braun; W H Oldendorf; R Hattner; H Parker
Journal:  J Nucl Med       Date:  1980-10       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.